November 2, 2016
(UPI) – Gene therapy shows promise in treating a genetic skin disease that causes blistering, according to researchers. In the early stage clinical trial, researchers from the Stanford University School of Medicine tested the therapy on four adults with recessive dystrophic epidermolysis bullosa. People with this skin condition aren’t able to produce a protein that binds the upper and lower levels of skin together. At the slightest friction, these layers slide and create blisters. In the worst cases, death occurs in infancy, the researchers said.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.